Nautilus Biotechnology, Inc. (NAUT) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Seattle, WA, United States. The current CEO is Sujal Patel.
NAUT has IPO date of 2020-08-07, 134 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $387.29M.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
